Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...

Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.

We have all this data that’s available, but it’s actually not actionable because we don’t have a way to get it into clinical ...

The medical device supplier said that a threat actor accessed company systems through a social engineering attack.

The program, a partnership with Kinomatic, will use biometric data and care coordination between visits to support recovery ...

Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding ...

Evidence generation is a strategic imperative in medtech, driving revenue, market access, and long-term business growth. Yet, ...

Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

Zimmer Biomet said Tuesday it has appointed Chintan Desai president of its Asia Pacific region, effective immediately. Desai ...